Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 28, 2024PLoS ONEOpen Access

Quality considerations and major pitfalls for high throughput DNA-based newborn screening for severe combined immunodeficiency and spinal muscular atrophy

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJessica BzdokLCLudwig CzibereSBSiegfried Burggraf

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bzdok et al. (2024) studied this question.

synapsesocial.com/papers/68e62c2eb6db6435875beb33https://doi.org/10.1371/journal.pone.0306329
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years2021 · 165 citations
  2. 2Future Perspectives of Newborn Screening for Inborn Errors of Immunity2021 · 24 citations
  3. 3A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS1963 · 2,243 citations
  4. 4A Review on Macroscale and Microscale Cell Lysis Methods2017 · 545 citations